Protein Cancer Biomarkers-Reference-Cited by-同舟云学术

Protein Cancer Biomarkers

Published:2023-01 Issue: Volume: Page:148-179
ISSN:
Container-title:Current Cancer Biomarkers
language:
Short-container-title:

Author:

Joseph Sarath S.¹,V. Tran Dan H.¹,Islam Farhadul²,Gopalan Vinod¹

Affiliation:

1. Griffith University,School of Medicine and Dentistry,Gold Coast,Australia,

2. University of Rajshahi,Department of Biochemistry and Molecular Biology,Rajshahi,Bangladesh,6205,

Abstract

Cancer is one of the leading causes of death worldwide and it is becoming increasingly important to be able to efficiently identify and map the progression of cancers. The study of the diagnostic, predictive and prognostic value of protein biomarkers has become one of the main aspects at the forefront of cancer research. The diversity of various biomarkers for different cancers and their varying roles in each disease presents a continual challenge for researchers to understand, with new biomarkers still being discovered today. Understanding the role of protein biomarkers ensures patients are diagnosed with greater confidence and helps clinicians with treatment regimes. This chapter aims to discuss the clinical significance of various protein biomarkers in terms of their diagnostic, prognostic, and predictive value in the treatment of their respective cancers.<br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference166 articles.

1. Barlow W.E.; Lehman C.D.; Zheng Y.; Ballard-Barbash R.; Yankaskas B.C.; Cutter G.R.; Carney P.A.; Geller B.M.; Rosenberg R.; Kerlikowske K.; Weaver D.L.; Taplin S.H.; Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst 2002,94(15),1151-1159

2. Ding L.; Zhang Z.; Shang D.; Cheng J.; Yuan H.; Wu Y.; Song X.; Jiang H.; α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma. J Oral Pathol Med 2014,43(5),335-343

3. Smitha A.; Rao K.; Umadevi H.S.; Smitha T.; Sheethal H.S.; Vidya M.A.; Immunohistochemical study of α-smooth muscle actin expression in oral leukoplakia and oral squamous cell carcinoma. J Oral Maxillofac Pathol 2019,23(1),59-64

4. Lee H.W.; Park Y.M.; Lee S.J.; Cho H.J.; Kim D.H.; Lee J.I.; Kang M.S.; Seol H.J.; Shim Y.M.; Nam D.H.; Kim H.H.; Joo K.M.; Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma. Clin Cancer Res 2013,19(21),5879-5889

5. da Silva A.C.; Jammal M.P.; Etchebehere R.M.; Murta E.F.C.; Nomelini R.S.; Role of Alpha-Smooth Muscle Actin and Fibroblast Activation Protein Alpha in Ovarian Neoplasms. Gynecol Obstet Invest 2018,83(4),381-387